Please assess the completion status of the following clinical trial:

Trial Title: Evolution of Dark Ideas When Introducing or Switching an Antidepressant

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Subject aged 18 to 65~* Diagnosis of a characterized depressive episode assessed by the clinician~* Depression score : MADRS\> 20~* Introduction or switch of an antidepressant (without combination of molecules)~* Signed informed consent~* Able to understand the nature, purpose and methodology of the study~* French language~* Able to understand and conduct clinical assessments.~Exclusion criteria:~* The following psychiatric comorbidities: Bipolar disorder, schizophrenia, alcohol dependence and / or any other substance objectivized during the clinical evaluation~* Patient presenting a depressive episode characterized with mixed component, psychotic, melancholic or catatonic characteristics~* Score MADRS greater than or equal to 5 to one of the items~* Subject protected by law (guardianship or curatorship)~* Subject in exclusion period from another protocol~* Subject not affiliated to, or not beneficiary of, a social security scheme~* Pregnant orbreastfeeding patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- depressed patients (Type: OTHER): All patients performed the same evaluation : ecological momentary assesement throught smartphone and 3 sheduled visits.~All patients are depressed patients.

Based on this trial design, predict the completion outcome and termination type (if applicable).